Profil
Sandra Cauwenberghs worked as an Analyst at KBC Securities NV from 2017 to 2020.
Dr. Cauwenberghs worked as Senior Director-Investor Relations at Lakefront Biotherapeutics.
Dr. Cauwenberghs worked as Head-Pharmacology at iTeos Therapeutics SA. Dr. Cauwenberghs earned a doctorate from Maastricht University.
Dr. Cauwenberghs earned a graduate degree from Katholieke Universiteit Leuven.
Anciens postes connus de Sandra Cauwenberghs
| Sociétés | Poste | Fin |
|---|---|---|
KBC Securities NV
KBC Securities NV Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/11/2020 |
| LAKEFRONT BIOTHERAPEUTICS NV | Investor Relations Contact | - |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Corporate Officer/Principal | - |
Formation de Sandra Cauwenberghs
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
Maastricht University
Maastricht University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KBC Securities NV
KBC Securities NV Investment Banks/BrokersFinance Provides brokerage services | Finance |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology Engages in the discovery of immunomodulators for cancer therapy | Health Technology |
















